Related Experiment Video
Updated: May 25, 2025

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Controversies in chronic histiocytic intervillositis
Virginie Collin-Bund1, Vincent Poindron2, Pauline Le Van Quyen3
1Department of Gynecology and Obstetrics, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; Laboratoire d'ImmunoRhumatologie Moléculaire, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR_S 1109, Institut thématique interdisciplinaire (ITI) de Médecine de Précision de Strasbourg, Transplantex NG, Faculté de Médecine, Fédération Hospitalo-Universitaire OMICARE, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, Strasbourg, France; Department of Maternal Fetal Medicine, Strasbourg University Hospital, Strasbourg, France.
Chronic histiocytic intervillositis (CHI) is a rare pregnancy complication involving maternal immune cells attacking the placenta. This review explores its causes, diagnosis, and management, highlighting severe fetal risks.
Area of Science:
- Reproductive Immunology
- Maternal-Fetal Medicine
- Pathology
Background:
- Chronic histiocytic intervillositis (CHI) is a rare placental inflammatory disease.
- It involves maternal CD68+ mononuclear immune cells infiltrating the intervillous space.
- CHI is associated with severe pregnancy complications and high recurrence rates.
Purpose of the Study:
- To review current knowledge on CHI.
- To focus on pathogenesis, diagnosis, and treatment.
- To cover advancements in the last 5 years.
Main Methods:
- Narrative review of literature.
- Focus on immunological mechanisms.
- Analysis of clinical associations and management strategies.
Main Results:
- Pathogenesis likely involves allo-immune rejection, not autoimmunity.
- CHI is linked to fetal growth restriction, miscarriage, and stillbirth.
- Standardized management guidelines are lacking.
Conclusions:
- CHI presents a significant challenge in pathological pregnancies.
- Further research is needed for effective, standardized treatment.
- Understanding the immune dysregulation is crucial for improving outcomes.
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

